| Trial ID: | L2270 |
| Source ID: | NCT00657930
|
| Associated Drug: |
Insulin Detemir
|
| Title: |
Observational Study in Type 2 Diabetes Treated by an Intensive Insulin Treatment (ICT) Containing Once Daily Levemir® (Insulin Detemir)
|
| Acronym: |
LEONCET2
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Diabetes|Diabetes Mellitus, Type 2
|
| Interventions: |
DRUG: insulin detemir
|
| Outcome Measures: |
Primary: Efficacy (HbA1c), 24 weeks | Secondary: Body weight, 24 weeks|Hypoglycaemia frequency, 24 weeks|FBG variability, 24 weeks|Insulin dose change, 24 weeks
|
| Sponsor/Collaborators: |
Sponsor: Novo Nordisk A/S
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
|
| Enrollment: |
2289
|
| Study Type: |
OBSERVATIONAL
|
| Study Designs: |
Observational Model: |Time Perspective: p
|
| Start Date: |
2008-03
|
| Completion Date: |
2009-04
|
| Results First Posted: |
|
| Last Update Posted: |
2016-03-03
|
| Locations: |
Budapest, 1025, Hungary
|
| URL: |
https://clinicaltrials.gov/show/NCT00657930
|
